Literature DB >> 403143

Reagin-like activity of serum in human peridonotal disease.

A Jayawardene, M Goldner.   

Abstract

The serum from patients with periodontitis produced a passive cutaneous anaphylaxis reaction in monkeys when tested against subgingival plaque. This detection of reaginic antibodies shows that patients with periodontitis make immunoglobulin E antibodies to plaque constituents.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 403143      PMCID： PMC421418          DOI： 10.1128/iai.15.2.665-667.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  6 in total

1.  Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity.

Authors:  K Ishizaka; T Ishizaka; M M Hornbrook
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

2.  Human reaginic antibodies and immunoglobulin E.

Authors:  K Ishizaka; T Ishizaka
Journal:  J Allergy       Date:  1968-12

3.  Relation of immediate hypersensitivity to periodontitis in animals and man.

Authors:  R J Nisengard; E H Beutner
Journal:  J Periodontol       Date:  1970-04       Impact factor: 6.993

4.  Immunologic studies of periodontal disease. V. IgG type antibodies and skin test responses to actinomyces and mixed oral flora.

Authors:  R J Nisengard; E H Beutner
Journal:  J Periodontol       Date:  1970-03       Impact factor: 6.993

5.  Immunofluorescence studies of IgE in periodontal disease.

Authors:  R J Nisengard; E H Beutner; M Gauto
Journal:  Ann N Y Acad Sci       Date:  1971-06-21       Impact factor: 5.691

6.  Immunologic studies of periodontal diseases. IV. Bacterial hypersensitivity and periodontal disease.

Authors:  R Nisengard; E H Beutner; S P Hazen
Journal:  J Periodontol       Date:  1968-11       Impact factor: 6.993
  6 in total
  1 in total

1.  The mechanism of basophil histamine release in patients with periodontal disease.

Authors:  A Olsson-Wennström; J L Wennström; S E Mergenhagen; R P Siraganian
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.